Lithium and Suicidal Behaviour in Patients With Bipolar Disorder
J Clin Psychiatry 2008;69:1831-1932 [letter]
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.
Sir: We read with great interest the excellent article by
Marangell et al. In this case-control analysis of the impact of
lithium (and other) pharmacotherapy on prospectively observed
suicidal behavior in patients with bipolar disorders, the authors
did not find an association between lithium (and other mood
stabilizer) use and suicide attempts or completed suicides. This
is in contrast with recent meta-analyses showing that in patients
with major mood disorders, long-term lithium treatment
reduces the risk of suicidal behavior by 60% to 90%.